Registration of Additional Securities (up to 20%) (s-1mef)
December 13 2016 - 6:14AM
Edgar (US Regulatory)
As
filed with the Securities and Exchange Commission on December 13, 2016
Registration
No. 333-
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
S-1
REGISTRATION
STATEMENT UNDER
THE
SECURITIES ACT OF 1933
SOLGENIX,
INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
2834
|
|
41-1505029
|
(State
or other jurisdiction of
incorporation or organization)
|
|
(Primary
Standard Industrial
Classification Code Number)
|
|
(I.R.S.
Employer
Identification No.)
|
Soligenix,
Inc.
29
Emmons Drive, Suite C-10
Princeton,
New Jersey 08540
(609)
538-8200
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Christopher
J. Schaber, Ph.D.
President
and Chief Executive Officer
Soligenix,
Inc.
29
Emmons Drive, Suite C-10
Princeton,
New Jersey 08540
(609)
538-8200
(Name,
address, including zip code, and telephone number, including area code, of agent for service)
Copies
to:
Leslie
J. Croland, Esq.
|
Leslie
Marlow, Esq.
|
Driscoll
R. Ugarte, Esq.
|
Hank
Gracin, Esq.
|
Duane
Morris LLP
|
Patrick
J. Egan, Esq.
|
200
South Biscayne Boulevard
|
Gracin
& Marlow, LLP
|
Suite
3400
|
The
Chrysler Building
|
Miami,
Florida 33131-2318
|
405
Lexington Avenue, 26th Floor
|
Approximate
date of commencement of proposed sale to the public
:
As soon as practicable after the effective date of this Registration
Statement.
If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933 check the following box. ☒
If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please
check the following box and list the Securities Act registration statement number of the earlier effective registration statement
for the same offering. ☒ 333-214038
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller
reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large
accelerated filer ☐
|
Accelerated
filer ☐
|
Non-accelerated
filer ☐
|
Smaller
reporting company ☒
|
|
|
(Do
not check if a smaller reporting company)
|
|
CALCULATION
OF REGISTRATION FEE
Title of each class of securities to be registered
|
|
Proposed maximum aggregate offering
price
(1)
|
|
|
Amount of registration fee
(1)(2)(3)
|
|
Common Stock, $0.001 par value
|
|
$
|
—
|
|
|
$
|
—
|
|
Common Stock Purchase Warrants
|
|
$
|
—
|
|
|
$
|
—
|
|
Shares of Common Stock, $0.001 par value per share, underlying Common Stock Purchase Warrants
(3)(4)(5)
|
|
$
|
637,963.22
|
|
|
$
|
73.94
|
|
Representative’s Warrants
|
|
|
—
|
|
|
|
—
|
|
Shares of Common Stock underlying Representative’s Warrants
|
|
$
|
—
|
|
|
$
|
—
|
|
Total
|
|
$
|
637,963.22
|
|
|
$
|
73.94
|
|
(1)
|
Estimated
solely for purposes of calculating the registration fee according to Rule 457(o) under the Securities Act of 1933, as amended
(the “Securities Act”).
|
(2)
|
The
Registrant previously registered an aggregate of $15,696,974.52 of its securities on
the Registrant’s Registration Statement on Form S-1 (File No. 333-214038) declared
effective on November 22, 2016, for which a filing fee of $1,819.29 was paid. In accordance
with Rule 462(b) promulgated under the Securities Act, an additional amount of securities
having a proposed maximum aggregate offering price of $637,963.22 is hereby registered.
|
(3)
|
Pursuant
to Rule 416, the securities being registered hereunder include such indeterminate number of additional securities as may be
issued after the date hereof as a result of stock splits, stock dividends or similar transactions.
|
(4)
|
Includes
shares of common stock the underwriters have the option to purchase to cover over-allotments, if any. This registration statement
also covers the preferred stock purchase rights issuable in accordance with the Rights Agreement, dated June 22, 2007, between
the Registrant and American Stock Transfer & Trust Company, as Rights Agent, which are presently attached to and trade
with the Registrant’s common stock.
|
(5)
|
There
will be issued a warrant to purchase one and one-quarter share of common stock for every share offered. The warrants are exercisable
at a per share price equal to 125% of the common stock public offering price.
|
This
Registration Statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule
462(b) under the Securities Act of 1933, as amended.
EXPLANATORY
NOTE AND INCORPORATION BY REFERENCE
This
registration statement is being filed with respect to the registration of additional warrants to purchase shares of common stock,
par value $0.001 per share, of Soligenix, Inc., a Delaware corporation, pursuant to Rule 462(b) under the Securities Act of 1933,
as amended. The contents of the earlier registration statement on Form S-1, as amended (File No. 333-214038), which was declared
effective by the Securities and Exchange Commission on November 22, 2016, and all exhibits thereto are incorporated in this registration
statement by reference.
The
required opinion and consents are listed on an Exhibit Index attached hereto and filed herewith.
The
Registrant hereby certifies that it (i) has initiated and released a wire transfer to transmit the filing fee set forth on the
cover page of this Registration Statement to the Securities and Exchange Commission's account as soon as practicable (but no later
than the close of business on December 13, 2016), (ii) will not revoke such wire transfer, and (iii) has sufficient funds in the
relevant account to cover the amount of such filing fee.
PART
II
INFORMATION
NOT REQUIRED IN PROSPECTUS
Item
16.
|
Exhibits
and Financial Statement Schedules.
|
All
exhibits filed with or incorporated by reference in Registration Statement No. 333-214038 are incorporated by reference into,
and shall be deemed part of, this registration statement, except the following, which are filed herewith.
Exhibit No.
|
|
Description of Exhibit
|
|
|
|
5.1*
|
|
Opinion of Duane Morris LLP LLP as to validity of the securities issued.
|
|
|
|
23.1*
|
|
Consent of EisnerAmper LLP, Independent Registered Public Accounting Firm.
|
|
|
|
23.2
|
|
Consent of Duane Morris LLP (included in Exhibit 5.1).
|
|
|
|
24.1†
|
|
Powers of Attorney
|
*
Filed or furnished herewith
†
Included on the signature page to the Registrant’s Registration Statement on Form S-1 (File No. 333-214038) filed with the
Commission on October 7, 2016.
SIGNATURES
Pursuant to the requirements
of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereunto duly authorized, in the City of Princeton, State of New Jersey, on the 13th day of December, 2016.
|
SOLIGENIX,
INC.
|
|
|
|
|
By:
|
/s/
Christopher J. Schaber
|
|
|
Christopher
J. Schaber, PhD
|
|
|
Chief
Executive Officer and President
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
By:
|
/s/
Christopher J. Schaber
|
|
Chairman,
President and Chief Executive Officer
|
|
December
13, 2016
|
|
Christopher
J. Schaber, PhD
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
By:
|
*
|
|
Director
|
|
December
13, 2016
|
|
Keith
L. Brownlie, CPA
|
|
|
|
|
|
|
|
|
|
|
By:
|
*
|
|
Director
|
|
December
13, 2016
|
|
Marco
M. Brughera, DVM
|
|
|
|
|
|
|
|
|
|
|
By:
|
*
|
|
Director
|
|
December
13, 2016
|
|
Gregg
A. Lapointe, CPA
|
|
|
|
|
|
|
|
|
|
|
By:
|
*
|
|
Director
|
|
December
13, 2016
|
|
Robert
J. Rubin, MD
|
|
|
|
|
|
|
|
|
|
|
By:
|
*
|
|
Director
|
|
December
13, 2016
|
|
Jerome
Zeldis, MD, PhD
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
Karen R. Krumeich
|
|
Senior
Vice President and
|
|
December
13, 2016
|
|
Karen
R. Krumeich
|
|
Chief
Financial Officer
(Principal Financial and Accounting Officer)
|
|
|
*
The undersigned does hereby sign this registration statement on behalf of the above indicated director of Soligenix, Inc. pursuant
to a power of attorney executed by such director.
|
By:
|
/s/
Karen R. Krumeich
|
|
|
|
|
|
Karen
R. Krumeich
|
|
|
|
|
2
Soligenix (NASDAQ:SNGX)
Historical Stock Chart
From Apr 2024 to May 2024
Soligenix (NASDAQ:SNGX)
Historical Stock Chart
From May 2023 to May 2024